Neuropeptide Y is a 36 amino acid polypeptide that was first isolated from the porcine brain in 1982.' It has been shown to be the most abundant neuropeptide in the central nervous system and is also widely distributed throughout the peripheral nervous system.2 Neuropeptide Y has also been isolated from the gastrointestinal tract with large concentrations found in the biliary tree.' Because of its extensive tissue localisation, its effects on a variety of biological systems has been assessed. Central administration of neuropeptide Y has been shown to affect diverse physiological functions and behaviours including cardiorespiratory, neuroendocrine, and reproductive control, and regulation of circadian rhythms, memory, and feeding behaviour.4'5 Indeed, neuropeptide Y is the most potent central stimulant of feeding known. 6 In addition, intracerebroventricular injection of neuropeptide Y increases gastric acid and pancreatic secretion in dogs, and it has been suggested that it may mediate the cephalic phase secretory response to feeding. 7 Despite the fact that the liver has an extensive neural network, the In the rat, after injection of control, bile output was 1-36 (0.008) ml/90 minutes for the period 30 to 120 minutes after injection (Fig 2) . After injection of neuropeptide Y (1000 pmol/rat), bile output over the same time period was 1.54 (0 23) ml/90 minutes, which represents a 13.2% increase in bile flow (p<005). Bilateral cervical vagotomy abolished this response (Fig 2) . Bile composition (bile acids, cholesterol, and phospholipids) was unaffected.
Discussion
This study shows a central stimulatory effect of neuropeptide Y on bile secretion that is mediated by the vagus nerve. The observation of a less noticeable stimulatory response to neuropeptide Y in the rat than in the dog may be explained by the fact that these rats were anaesthetised with urethane which is known to cause release of somatostatin -a known universal inhibitor ofgut secretions.'5 A further explanation could be that rats have a small ductular component of bile secretion which may have been the primary target of the observed response, as evidenced by the increase in biliary bicarbonate output observed in the canine studies. Intravenous infusion of neuropeptide Y did not affect bile secretion suggesting that the choleretic effect of intracerebroventricular neuropeptide Y was not the result of peripheral leakage of the peptide across the blood brain barrier. In addition, the effect was not secondary to secretin release caused by duodenal acidification as this was avoided by pretreatment with omeprazole and diversion of gastric secretions.
Despite the fact that there have been many reports describing the central effects of neuropeptides on gastric and pancreatic secretion, there has been only one previous report of the effects of a centrally acting peptide on biliary secretion. In that study, Yao Time (hours) However, a direct vasomotor effect of central neuropeptide Y on the hepatic artery vasculature, resulting in increased blood flow, cannot be ruled out entirely and may indeed be the mechanism causing the observed effect on biliary secretion in dogs where the arterial component to blood flow is significant as opposed to rats.
Because of its effects on feeding, and gastric and pancreatic secretion, it has been suggested that neuropeptide Y is a mediator of the cephalic phase secretory response to feeding. The site of neuropeptide Y's action on feeding seems to be in the hypothalamus, and it is likely that the cephalic phase response is also integrated at this level.2' The effect on bile secretion seen after intracerebroventricular injection of neuropeptide Y in these studies may therefore be the result of neuropeptide Y binding to receptors responsible for releasing cephalic phase secretion. Although nerve fibres are abundant in the liver, particularly in the portal triads, their metabolic importance remains obscure. Central nervous system regulation of hepatic function may provide a mechanism by which bile production is integrated with other metabolic activities particularly, digestive functions. Central neuropeptide Y release may be the primary stimulus for an integrated feeding response that includes the secretion of alkaline bile.
